Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Professor Maggie Dallman OBE, who was a member of the Nuffield Department of Surgical Sciences (NDS) from 1984 to 1994, has been appointed the first Vice President (International) at Imperial College London. Sir Peter J Morris reports on her outstanding scientific career so far.

© Imperial College London

Maggie Dallman joined my research group in the NDS from Stanford in 1984 as a Nuffield Research Fellow, and also as a Research Fellow at Hertford College. She soon developed her own research team and had a most productive 10 years in the NDS. She left to take up a Lecturer appointment at Imperial College in 1994 and rose through the ranks there because of her distinguished research record to become Professor of Immunology and most recently she has just been appointed as first Vice President (International) at Imperial College London. 

When she joined the NDS it was to study cellular mechanisms of graft rejection but, indeed, she changed the activities of her group within the NDS to concentrate on the role of cytokine and cytokine-receptor expression in graft rejection and tolerance induction. In this area she did some very outstanding work in rat models as well as in the human, particularly as related to the role of IL-2. 

I was looking back through the NDS reports and if I can quote the comment in 1994: 'Dr Maggie Dallman was appointed as a Lecturer in Immunology at Imperial College taking up the position in November 1994. Maggie will be missed by everybody in the NDS and indeed in the Clinical School as she had combined an outstanding scientific career with a delightful personality, which endeared her to both her students and colleagues. Fortunately she has continued collaborating with the NDS in a number of areas and has been appointed as a Visiting Fellow to the NDS.'   

Having read that it is obvious why she did so well in not only research but in administrative roles at Imperial and was the Associate Provost as well as Professor of Immunology. Her new appointment will be directed at international collaboration between Imperial and leading institutions from other regions in the world, but she will continue her research in immunology.

Sir Peter J Morris, AC, FRS

Similar stories

Another successful year for SITU NDS

The Surgical Intervention Trials Unit in the Nuffield Department of Surgical Sciences (SITU NDS) has had another successful year, now running ten randomised controlled trials across surgical specialties and securing a total of £32 million in current peer-reviewed grants.

NDS projects awarded CRUK Oxford Cancer Development Fund

Two research projects at the Nuffield Department of Surgical Sciences (NDS) have been awarded pump-prime funding from this year’s CRUK Oxford Centre Development Fund.

DPhil student awarded prestigious prize by Italian medical academy

This year’s winner of the prestigious Giovanni Maria Lancisi Award is Dr Pierfrancesco Lapolla Losasso, DPhil candidate at Nuffield Department of Surgical Sciences (NDS), presenting the research project 'Combined physiological and biochemical approach for the prediction of abdominal aortic aneurysm growth in humans' conducted through the OxAAA study.

Blog posts

Lights, camera, action! My journey into video production

Dr Hannah McGivern provides a 'behind-the-scenes' account of her experience producing the video 'Journey of a QUOD Sample: Donating to Transplant Research', supported by the funds from the University of Oxford Public Engagement with Research (PER) Seed Fund.

Mentoring in practice

NDS has launched a new, interdepartmental mentoring scheme called RECOGNISE. In this podcast, Gemma Horbatowski (HR Advisor) interviews Monica Dolton (Programme Manager and Research Project Manager) about her experiences of mentor-mentee relationships.

Wrap up of 2021

After a brilliant year of hard work and dedication, the SITU team has done some reflection on 2021, focusing on key events, trial progression, and more. Read on to discover how the year 2021 went for the SITU team...